Physician profile
Ankur Chandra
NPI 1336462670
$13,422.66
in general payments reported to CMS, 2019-2025
27 companies · $3,503 in 2025
The $3,503 reported for 2025 was more than what 80% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,590 · 2020: $506 · 2021: $2,645 · 2022: $1,806 · 2023: $939 · 2024: $433 · 2025: $3,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,300 · Food and Beverage: $2,000 · Consulting Fee: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,300.00 |
| Food and Beverage | $2,000.02 |
| Consulting Fee | $575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,987.74 | 2019-2025 | Esprit, Perclose Proglide |
| Medtronic, INC. | $1,046.24 | 2021-2025 | Venaseal, Endurant Iis, Closurefast |
| W. L. Gore & Associates, INC. | $988.44 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $616.54 | 2019-2022 | |
| Medtronic Vascular, INC. | $352.60 | 2019-2020 | |
| Silk Road Medical, INC. | $305.14 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $142.24 | 2020-2025 | Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $129.86 | 2019-2025 | Crosser Iq, Rotarexs 6 F X 135 Cm |
| Baxter Healthcare | $108.53 | 2020-2025 | Preveleak |
| Janssen Pharmaceuticals, INC | $94.18 | 2019-2022 | |
| Angiodynamics, INC. | $76.09 | 2022-2023 | Alphavac |
| Reflow Medical INC | $72.70 | 2024-2025 | |
| Bolton Medical INC | $70.75 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Inari Medical, INC. | $67.38 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acera Surgical, INC. | $44.08 | 2023-2024 | Restrata Wound Matrix |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $41.70 | 2025 | |
| Davol INC. | $37.04 | 2024 | Venclose Maven Catheter |
| Lemaitre Vascular, INC. | $36.26 | 2020-2022 | |
| Stryker Corporation | $31.90 | 2025 | Artix Mt |
| Penumbra, INC. | $30.00 | 2019 | |
| Getinge USA Sales, LLC | $28.12 | 2019 | |
| Tactile Systems Technology INC | $20.96 | 2019 | |
| Philips North America LLC | $20.40 | 2025 | Visions 014 |
| Medline Industries LP | $19.96 | 2019 | |
| Kci USA, INC. | $19.47 | 2022 | |
| Artivion, INC. | $17.29 | 2025 | Photofix Decellularized Bovine Pericardium, Vascular |
| E.R. Squibb & Sons, L.L.C. | $17.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.